ANTEROGEN CO., LTD.
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
065660 | KO
Overview
Corporate Details
- ISIN(s):
- KR7065660003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 금천구 디지털로 130, 405호(가산동, 남성플라자), 서울특별시
- Website:
- http://anterogen.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Anterogen Co., Ltd. is a biotechnology company specializing in the research, development, and commercialization of cell therapy products and orphan drugs. The company's core technology leverages adult stem cells, particularly adipose-derived stem cells (ASCs), to create treatments for various medical conditions. Established with a research institute in 2000, Anterogen was a pioneer in the commercialization of ASC-based therapies in its domestic market. Its product pipeline is developed through clinical trials and focuses on leveraging the immune-modulating effects of its proprietary stem cell technology. The company manages the full lifecycle of its products, from research to manufacturing and distribution.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 813.1 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 798.1 KB | ||
| 2025-03-21 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 22.9 KB | ||
| 2025-03-21 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.0 KB | ||
| 2025-03-13 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 17.8 KB | ||
| 2025-03-13 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.0 MB | ||
| 2025-02-26 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 132.6 KB | ||
| 2025-02-20 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 10.3 KB | ||
| 2025-02-20 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 4.9 KB | ||
| 2025-02-10 00:00 |
Regulatory News Service
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 36.4 KB | ||
| 2025-01-31 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시) (제3자배정 유상증자)
|
Korean | 5.6 KB | ||
| 2025-01-31 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험결과) (Wagner grade 1 당뇨병성 족부궤양 환자를 대상으로 한 ALLO-ASC…
|
Korean | 11.4 KB | ||
| 2025-01-23 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 25.9 KB | ||
| 2024-12-09 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-11-14 00:00 |
Quarterly Report
분기보고서 (2024.09)
|
Korean | 762.7 KB |
Automate Your Workflow. Get a real-time feed of all ANTEROGEN CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ANTEROGEN CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ANTEROGEN CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
